Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-082820
Filing Date
2026-02-27
Accepted
2026-02-27 16:30:16
Documents
1
Period of Report
2026-02-26

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6446
  Complete submission text file 0001193125-26-082820.txt   8094
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON United Kingdom W1G 0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON United Kingdom W1G 0QF 4403330237300
Mereo BioPharma Group plc (Issuer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MEREO BIOPHARMA 1 CAVENDISH PLACE LONDON X0 W1G 0QF
Business Address
Ekblom Anders (Reporting) CIK: 0002005817 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38452 | Film No.: 26700565